A Phase II Study of the Combination of Aflibercept (VEGF-Trap) Plus Modified FOLFOX 6 in Patients With Previously Untreated Metastatic Colorectal Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 26 May 2018
At a glance
- Drugs Aflibercept (Primary) ; Fludeoxyglucose F-18; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- 03 Apr 2018 Planned End Date changed from 1 Sep 2018 to 31 Dec 2018.
- 03 Apr 2018 Planned primary completion date changed from 31 Dec 2017 to 31 Dec 2018.
- 15 Sep 2017 Planned primary completion date changed from 1 Sep 2017 to 31 Dec 2017.